Recommending authorized practitioner; protections.
Effective Mar 22, 2023Feb. 25, 2010, D.C. Law 13-315, § 5; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(d); Dec. 3, 2020, D.C. Law 23-149, § 5012(c); Mar. 22, 2023, D.C. Law 24-332, § 3(d)
- (a) A qualifying patient may receive a recommendation from an authorized practitioner to use medical cannabis for a qualifying medical or dental condition or a qualifying medical or dental treatment.
- (b) An authorized practitioner may recommend the use of medical cannabis to a qualifying patient, on a form provided by ABCA, if the authorized practitioner makes the recommendation based on an assessment of the qualifying patient's current medical or dental condition.
- (c) An authorized practitioner shall not be subject to any penalty, including arrest, prosecution, or disciplinary proceeding, or denial of any right or privilege, for advising a qualifying patient about the use of medical cannabis or recommending the use of medical cannabis to a qualifying patient pursuant to this chapter and any rules issued pursuant to § 7-1671.13.
- (d) An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not have a professional office located at a retailer, internet retailer, cultivation center, manufacturer, or testing laboratory or receive financial compensation from a cultivation center, manufacturer, or testing laboratory, or a director, officer, member, incorporator, agent, or employee of a retailer, internet retailer, cultivation center, courier, manufacturer, or testing laboratory.
History
Feb. 25, 2010, D.C. Law 13-315, § 5
as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798
Feb. 18, 2017, D.C. Law 21-209, § 2(d)
Dec. 3, 2020, D.C. Law 23-149, § 5012(c)
Mar. 22, 2023, D.C. Law 24-332, § 3(d)
Section References
This section is referenced in § 3-1202.03 and § 7-1671.02.
Emergency Legislation
For temporary (90 days) amendment of this section, see § 2(a) of Medical Cannabis Patient Card Extension and 4/20 Medical Cannabis Sales Tax Holiday Week Emergency Amendment Act of 2024 (D.C. Act 25-437, Apr. 8, 2024, 71 DCR 4118).
For temporary (90 days) amendment of this section, see § 2(a) of Medical Cannabis Patient Card Extension and 4/20 Medical Cannabis Sales Tax Holiday Week Congressional Review Emergency Amendment Act of 2024 (D.C. Act 25-526, July 23, 2024, 71 DCR 9590).
Temporary Legislation
For temporary (225 days) amendment of this section, see § 2(a) of Medical Cannabis Patient Card Extension and 4/20 Medical Cannabis Sales Tax Holiday Week Temporary Amendment Act of 2024 (D.C. Law 25-193, July 19, 2024, 71 DCR 6749).